Published ahead of print on November 14, 2003, doi:10.1164/rccm.200305-669OC
American Journal of Respiratory and Critical Care Medicine Vol 169. pp. 454-458, (2004)
© 2004 American Thoracic Society
Mouse Lysozyme M Is Important in Pulmonary Host Defense against Klebsiella pneumoniae Infection
Philipp Markart,
Thomas R. Korfhagen,
Timothy E. Weaver and
Henry T. Akinbi
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Correspondence and requests for reprints should be addressed to Henry T. Akinbi, M.D., Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229–3039. E-mail: henry.akinbi{at}cchmc.org
Klebsiella pneumoniae is a common virulent causative agent for pneumonia. Lysozyme has previously been shown to play an important role in nonimmune host defense of the airways. This study was undertaken to assess the role of lysozyme M, the major isoform of lysozyme in mouse lung, in the killing of K. pneumoniae in lysozyme M-/- mice and transgenic mice with increased expression of lysozyme (lysozymetg mice). The airways of lysozyme M-/- mice maintained in a pathogen-free facility were colonized by Lactobacilli, a component of the oropharyngeal flora. No lactobacilli were detected in the lungs of wild-type (WT) or lysozymetg mice. Twenty-four hours after intratracheal infection with K. pneumoniae, bacterial killing was enhanced 9-fold in lysozymetg mice compared with WT mice and 43-fold compared with lysozyme M-/- mice. In survival studies, no lysozyme M-/- mice survived beyond 72 hours after infection, whereas 75% of lysozymetg (p < 0.01) and 25% of WT mice survived to 120 hours (p < 0.01). Deficiency of lysozyme M in the lungs increased susceptibility to K. pneumoniae infection, whereas increased expression of lysozyme conferred resistance to infection and enhanced survival.
Key Words: lysozyme • knockout • Klebsiella pneumonia
This article has been cited by other articles:
|
|
|
|
 
J. A. Nash, T. N. S. Ballard, T. E. Weaver, and H. T. Akinbi
The Peptidoglycan-Degrading Property of Lysozyme Is Not Required for Bactericidal Activity In Vivo
J. Immunol.,
July 1, 2006;
177(1):
519 - 526.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Cole, D. R. Thapa, V. Gabayan, H.-I Liao, L. Liu, and T. Ganz
Decreased clearance of Pseudomonas aeruginosa from airways of mice deficient in lysozyme M
J. Leukoc. Biol.,
November 1, 2005;
78(5):
1081 - 1085.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. L. Nesslein, K. R. Melton, M. Ikegami, C.-L. Na, S. E. Wert, W. R. Rice, J. A. Whitsett, and T. E. Weaver
Partial SP-B deficiency perturbs lung function and causes air space abnormalities
Am J Physiol Lung Cell Mol Physiol,
June 1, 2005;
288(6):
L1154 - L1161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Harder and J.-M. Schroder
Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins
J. Leukoc. Biol.,
April 1, 2005;
77(4):
476 - 486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Muller, N. Subert, H. Otto, R. Herbst, H. Ruhling, M. Maniak, and M. Leippe
A Dictyostelium Mutant with Reduced Lysozyme Levels Compensates by Increased Phagocytic Activity
J. Biol. Chem.,
March 18, 2005;
280(11):
10435 - 10443.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Angus, A. Ishizaka, M. Matthay, F. Lemaire, W. MacNee, and E. Abraham
Critical Care in AJRCCM 2004
Am. J. Respir. Crit. Care Med.,
March 15, 2005;
171(6):
537 - 544.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Fessler, S. K. Young, S. Jeyaseelan, J. G. Lieber, P. G. Arndt, J. A. Nick, and G. S. Worthen
A Role for Hydroxy-Methylglutaryl Coenzyme A Reductase in Pulmonary Inflammation and Host Defense
Am. J. Respir. Crit. Care Med.,
March 15, 2005;
171(6):
606 - 615.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Skerrett
Lysozyme in Pulmonary Host Defense: New Tricks for an Old Dog
Am. J. Respir. Crit. Care Med.,
February 15, 2004;
169(4):
435 - 436.
[Full Text]
[PDF]
|
|
|
Copyright © 2004 American Thoracic Society
|
|
|
